Domov › Ploščatocelični karcinom glave in vratu › Connecticut
Klinične študije za Ploščatocelični karcinom glave in vratu v Connecticut
24 študij za Ploščatocelični karcinom glave in vratu išče udeležence na lokacijah v Connecticut.
Mesta v Connecticut
Uradno besedilo študije (angleško)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #62, New Haven
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT05176483A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- in še 1
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07090499Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
- Yale University - Yale University School of Medicine, New Haven
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07360314A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Hartford Hospital, Hartford
- Yale Cancer Center, New Haven
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07276399A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- Yale Cancer Center, New Haven
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06385080A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, New Have
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07229313Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull
- in še 1
Vključevanje udeležencevFaza 2
Starost 18–79 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT04671667Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Yale University, Yale Cancer Center, New Haven
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05983432Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich
- Smilow Cancer Hospital Care Center - Guilford, Guilford
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- in še 4
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT02734537First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- Yale Cancer Center, New Haven
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT06657222ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
- Yale University Cancer Center, New Haven
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06597721A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, New Haven
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07182149Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- Yale University, New Haven
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT04333537CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
- Yale University, New Haven
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 30. jul. 2026 · NCT07172256A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
- Yale Comprehensive Cancer Center, New Haven
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT06747585Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Yale University, Yale Cancer Center, New Haven
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT069938445-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
- Yale University, New Haven
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 10. jun. 2026 · NCT05317000Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Yale University School of Medicine /ID# 225707, New Haven
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 4. jun. 2026 · NCT04777994A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Farmington
- GSK Investigational Site, New Haven
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 26. maj 2026 · NCT06256588A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Yale School of Medicine - Smilow Cancer Hospital, New Haven
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 9. apr. 2026 · NCT06064877VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Hartford Hospital (site 210), Hartford
Vključevanje udeležencevFaza 1/2
Starost 18–80 · Vsi spoli · Posodobljeno 11. dec. 2025 · NCT03556228A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Yale Cancer Center, New Haven
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 4. nov. 2025 · NCT05902988Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Yale Cancer Center, New Haven
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 15. nov. 2024 · NCT04787042Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
- Yale, New Haven
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 18. mar. 2024 · NCT05280314Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.